早发型胎儿生长受限妊娠的围产期风险评估:复合不良围产结局预测模型的开发与内部验证
在荷兰六家学术医院开展回顾性多中心队列研究,开发并内部验证早发型胎儿生长受限入院时预测复合不良围产结局的模型。共560/1453(38.5%)妊娠发生复合不良围产结局,模型含14个预测变量,内部验证后AUC 0.83(95%CI 0.79-0.87),校准斜率1.05(95%CI 0.94-1.17)。作者认为该模型可能有助于临床决策和父母咨询,但需外部验证及评估对临床决策和患者结局的影响后方可常规应用。
要点
- 早发型胎儿生长受限入院时可用14个常规变量预测复合不良围产结局。
- 模型内部验证AUC 0.83(95%CI 0.79-0.87),校准斜率1.05(95%CI 0.94-1.17)。
- 作者认为该模型可能有助于临床决策和父母咨询,但需外部验证后再常规应用。
核心结论
- 包含14个易获取预测变量的模型在入院时对复合不良围产结局预测表现良好,可能作为早发型胎儿生长受限临床决策和父母咨询的有用工具。
- 在常规临床实践应用前,需进行外部验证并评估模型对临床决策和患者结局的影响。
研究设计与样本
- 在荷兰六家学术医院开展的回顾性、多中心队列研究(OPTICORE研究),研究对象为符合共识定义的早发型胎儿生长受限妊娠。
- 候选预测变量基于现有文献和专家意见选择,包括母亲病史、产科病史、胎儿生长和超声多普勒评估。
- 采用基于Akaike信息准则的后向逐步消除法筛选变量,通过自举法重复预测变量选择过程进行内部验证以确定收缩因子校正过拟合,并采用内部-外部交叉验证作为敏感性分析评估各医院内患者聚集的影响。
主要发现
- 共560/1453(38.5%)妊娠发生复合不良围产结局。
- 最终模型包含14个预测变量:母亲慢性肾脏病或慢性高血压病史、吸烟、既往胎儿生长受限妊娠、入院时孕龄、胎儿性别、合并子痫前期、使用硫酸镁、妊娠期糖尿病、估计胎儿体重、脐动脉和大脑中动脉搏动指数百分位、脐动脉舒张末期血流缺失或反向、诊断胎儿生长受限时孕龄。
- 内部验证和收缩校正乐观度后,模型表现良好:受试者工作特征曲线下面积0.83(95%CI 0.79-0.87),校准斜率1.05(95%CI 0.94-1.17),大范围校准0.07(95%CI -0.06至0.20)。
- 内部-外部交叉验证敏感性分析显示,在三个最大医院间模型性能指标相当。
关键数值与推荐
- 复合不良围产结局定义为一个或多个以下事件:围产期或住院期间死亡、坏死性小肠结肠炎≥IIA期、中重度支气管肺发育不良、囊性脑室周围白质软化、脑室内出血≥III级或静脉梗死和/或培养证实的脓毒症。
临床怎么用
- 作者认为该模型可能作为早发型胎儿生长受限入院时临床决策和父母咨询的有用工具。
- 作者指出在常规临床实践应用前需进行外部验证并评估模型对临床决策和患者结局的影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Early-onset fetal growth restriction (FGR) frequently requires iatrogenic preterm delivery to prevent stillbirth or the sequelae of hypoxia. A prediction model for adverse perinatal outcome could aid clinical decision-making and parental counseling. However, an adequate externally validated model, including predictors that are readily available for this purpose, is currently lacking. The aim of the present study was to develop a prediction model for composite adverse perinatal outcome (CAPO) to be used at the time of hospital admission for fetal monitoring in early-onset FGR. METHODS: A model was developed to predict CAPOs (defined as one or more of the following: perinatal or in-hospital mortality, necrotizing enterocolitis ≥ Stage IIA, moderate or severe bronchopulmonary dysplasia, cystic periventricular leukomalacia, intraventricular hemorrhage ≥ Grade III or venous infarction and/or culture-proven sepsis) in early-onset FGR. The model was developed and internally validated in the OPTICORE study, a retrospective, multicenter cohort study of pregnancies complicated by early-onset FGR, in accordance with the consensus-based definition, in six academic hospitals in The Netherlands. Candidate predictors were selected based on the existing literature and expert opinion and comprised maternal medical history, obstetric history, fetal growth and Doppler assessment. A backward stepwise elimination procedure was performed based on the Aikake Information Criterion. Internal validation was performed by bootstrapping and repeating the predictor selection process to determine the shrinkage factor to adjust for overfitting. Internal-external cross-validation was performed as a sensitivity analysis to assess the impact of clustering of patients within each hospital. RESULTS: In total, 560/1453 (38.5%) pregnancies were complicated by CAPO. The developed model included 14 predicting variables, determined at the time of hospital admission for fetal monitoring: maternal history of chronic kidney disease or chronic hypertension, smoker, previous pregnancy complicated by FGR, gestational age at admission, fetal sex, concomitant pre-eclampsia, the use of magnesium sulfate, gestational diabetes mellitus, estimated fetal weight, umbilical artery and middle cerebral artery pulsatility index percentile, absent or reversed end-diastolic flow in the umbilical artery and gestational age at diagnosis of FGR. After internal validation and shrinkage to adjust for optimism, the model performed well (area under the receiver-operating-characteristics curve, 0.83 (95% CI, 0.79-0.87); calibration slope, 1.05 (95% CI, 0.94-1.17); calibration-in-the-large, 0.07 (95% CI, -0.06 to 0.20)). The internal-external cross-validation sensitivity analysis revealed equivalent model performance measures across the three largest hospitals. CONCLUSIONS: The developed model, including 14 readily available predictors, showed good performance for the prediction of CAPO at the time of hospital admission and may serve as a helpful tool for clinical decision-making and parental counseling in the setting of early-onset FGR. External validation and assessment of the model's impact on clinical decision-making and patient outcomes are required before it can be implemented in routine clinical practice. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- van de Meent M, Bel EW, Ganzevoort W, et al. Perinatal risk assessment in pregnancies complicated by early-onset fetal growth restriction: development and internal validation of a prediction model for composite adverse perinatal outcome. Ultrasound Obstet Gynecol. 2025. PMID: 40623699. doi:10.1002/uog.29265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。